Prostate Cancer is the second leading cause of death in men in the U.S, with over 1 in 41 men likely to succumb to the disease. According to an estimate by the American Cancer Society there would be 174,650 new cases of prostate cancer and...
Ovid Therapeutics (NASDAQ: OVID), a biopharmaceutical company developing novel therapeutics for rare neurological disorders, announced the launch of a crucial phase 3 clinical trial in Angelman Syndrome named NEPTUNE. OV101, its lead candidate for the treatment of syndrome and Fragile X Syndrome is a delta-selective...
People around the word may be separated by geographical boundaries, ethnicities and religion but one thing that unites them all is FACEBOOK! Facebook is ubiquitous, from your neighbour to the neighbourhood supermarket, from your workplace to the bank, everyone has a facebook identity. 15 years ago, when...
Liberty Defense Holdings (OTCPK: LDDFF), a pioneer in security solutions dealing with detection of concealed weapons in areas with high volume foot traffic, has signed a Memorandum of Understanding (MOU) with FC Bayern München, a premier German soccer team to test “HEXWAVE”. Beta testing will involve...
Sirona Biochem (OTCPK: SRBCF), a biopharmaceutical company focused on discovering novel cosmetic and pharmaceutical compounds, announced the grant of a patent for TFC-1067, its lead skin lightening compound. It uses its proprietary fluorination chemistry, to create unique and superior compounds, which are hydroquinone free and...
Severe combined immunodeficiency (SCID) or “Bubble Boy Syndrome” is a rare genetic disorder caused by gene mutations that inhibit the functioning of immune cells. Children afflicted with this condition are healthy in appearance but are susceptible to severe infections, even a common cold can prove...
Standing Tall ReWalk Robotics (NASDAQ: RWLK) recently received an approval for its ReStore exoskeleton system, indicated for rehabilitation of stroke victims, from the FDA. The company also manufactures ReWalk robotic exoskeleton, the first to receive FDA approval for personal and rehabilitation use in the United States. It...
Human Immunodeficiency Virus (HIV) compromises the body’s immunity by attacking CD4 cells (a type of T cell), exposing it to a host of infections and diseases and ultimately leading to the development of AIDS. According to data provided by Centres for Disease Control and Prevention,...
Obalon Therapeutics (NASDAQ: OBLN), the manufacturer of the first and only FDA-approved swallowable, gas-filled intragastric balloon system to combat obesity, has announced the grant of U.S patent no. 10,264,995 entitled “SYSTEMS AND METHODS FOR LOCATING AND/OR CHARACTERIZING INTRAGASTRIC DEVICES. This will help expand the company’s...
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinical trials of GEN-009, its neoantigen vaccine candidate. There has been a stream of positive news from the company’s stables off late, including news of Journal of Clinical Oncology® selecting...
